3SBio, (FRA:YFK) Other Gross PPE : €0.0 Mil (As of Dec. 2016)

View and export this data going back to . Start your Free Trial

What is 3SBio, Other Gross PPE?

3SBio,'s Other Gross PPE for the quarter that ended in Dec. 2016 was €0.0 Mil.

3SBio,'s quarterly Other Gross PPE increased from Dec. 2015 (€-0.0 Mil) to Jun. 2016 (€275.4 Mil) but then declined from Jun. 2016 (€275.4 Mil) to Dec. 2016 (€0.0 Mil).

3SBio,'s annual Other Gross PPE declined from Dec. 2014 (€0.0 Mil) to Dec. 2015 (€-0.0 Mil) but then increased from Dec. 2015 (€-0.0 Mil) to Dec. 2016 (€0.0 Mil).

3SBio, Other Gross PPE Historical Data

The historical data trend for 3SBio,'s Other Gross PPE can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

3SBio, Other Gross PPE Chart

3SBio, Annual Data

Trend

Dec06

Dec07

Dec08

Dec09

Dec10

Dec11

Dec12

Dec14

Dec15

Dec16

Other Gross PPE

Get a 7-Day Free Trial

3SBio, Semi-Annual Data
	Jun06	Dec06	Jun07	Dec07	Jun08	Dec08	Jun09	Dec09	Jun10	Dec10	Jun11	Dec11	Jun12	Dec12	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16
Other Gross PPE	Get a 7-Day Free Trial															-	51.73	-	275.36	-

3SBio, Other Gross PPE Calculation

GuruFocus lists Land And Improvements, Buildings And Improvements, Machinery, Furniture, Equipment, Construction In Progress and Other Gross PPE under the "Gross Property, Plant and Equipment" section.

3SBio, (FRA:YFK) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » 3SBio, Inc. (FRA:YFK) » Definitions » Other Gross PPE

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

http://www.3sbio.com

3SBio Inc is engaged in the healthcare sector based in China. It is a pharmaceutical products company and its core activities pertain to developing, manufacturing and marketing biopharmaceuticals. Its portfolio of products comprises of TPIAO and Yisaipu. TPIAO is the only commercialized recombinant human thrombopoietin (rhTPO) product in the world and Yisaipu is a TNF inhibibator product and accounts for the major share in the pharmaceutical industry in China. Most of the company's activities are focused on China while having a minor footprint in a foreign land.

3SBio, (FRA:YFK) Headlines

No Headlines